Navigation path

Pharmaceuticals - Union Register

  

Register of orphan medicinal products


GRANTED  

Product information

Human monoclonal antibody against human interleukin 13

EU orphan designation number: EU/3/13/1205   
Active ingredient: Human monoclonal antibody against human interleukin 13
Indication: Treatment of eosinophilic oesophagitis
Sponsor: Novartis Europharm Limited
Vista Building, Elm Park, Merrion Road, Dublin 4, Ireland

   Public summary of scientific opinion    

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
15/11/2013 Orphan designation EMA/OD/118/13 (2013)8052 of 13/11/2013
29/08/2014 Change of name and/or address of sponsor
16/05/2018 Transfer of orphan designation EMA/OD/118/13/T/01 (2018)3042 of 8/05/2018